Shopping Cart
- Remove All
Your shopping cart is currently empty
ZG-126 is an agonist of the vitamin D receptor (VDR) and an inhibitor of histone deacetylase (HDAC) with an IC50 range of 0.63-67.6 μM. It demonstrates cytotoxicity in cancer cell lines MDA-MB-231 and 4T1. In mouse models, ZG-126 exhibits antitumor and antimetastatic effects against melanoma and triple-negative breast cancer (TNBC). Additionally, it shows anti-inflammatory activity by reducing macrophage infiltration and polarization to the immunosuppressive M2 subtype.


| Description | ZG-126 is an agonist of the vitamin D receptor (VDR) and an inhibitor of histone deacetylase (HDAC) with an IC50 range of 0.63-67.6 μM. It demonstrates cytotoxicity in cancer cell lines MDA-MB-231 and 4T1. In mouse models, ZG-126 exhibits antitumor and antimetastatic effects against melanoma and triple-negative breast cancer (TNBC). Additionally, it shows anti-inflammatory activity by reducing macrophage infiltration and polarization to the immunosuppressive M2 subtype. |
| Targets&IC50 | HDAC11:2.02 μM, HDAC8:3.31 μM, HDAC1:2.53 μM, HDAC2:4.64 μM, HDAC5:59.4 μM, HDAC7:55.4 μM, HDAC4:67.6 μM, HDAC3:0.997 μM, HDAC6:0.633 μM, HDAC10:13.9 μM |
| Molecular Weight | 513.67 |
| Formula | C29H43N3O5 |
| Cas No. | 3049802-32-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.